CLPXF yields 5.33% · JNJ yields 2.13%● Live data
📍 CLPXF pulled ahead of the other in Year 1
Combined, CLPXF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CLPXF + JNJ for your $10,000?
China Longyuan Power Group Corporation Limited generates and sells wind and coal power in the People's Republic of China. It operates through segments, Wind Power and Coal Power. The company designs, develops, constructs, manages, and operates wind and coal power plants. It also operates other power projects, such as thermal, solar, tidal, biomass, and geothermal solar power. In addition, the company is involved in the coal trading business. Further, it manufactures and sells power equipment; provides consulting, maintenance, and training services to wind and other renewable power generation plants; and generates electric power for external power grid companies. The company was formerly known as China Longyuan Electric Power Group Corporation and changed its name to China Longyuan Power Group Corporation Limited in July 2009. The company was founded in 1993 and is headquartered in Beijing, the People's Republic of China. China Longyuan Power Group Corporation Limited operates as a subsidiary of China Energy Investment Corporation Limited.
Full CLPXF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.